Moving beyond the classic difference-in-differences model: A simulation study comparing 
statistical methods for estimating effectiveness of state-level policies 

Beth Ann Griffin 
RAND Corporation, Arlington, VA 22202 

Megan S. Schuler 
RAND Corporation, Boston, MA 02116 

Elizabeth A. Stuart 
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205 

Stephen Patrick 
Vanderbilt University Medical Center and School of Medicine, Nashville, TN 37232 

Elizabeth McNeer 
Vanderbilt University Medical Center, Nashville, TN 37232 

Rosanna Smart 
RAND Corporation, Santa Monica, CA 90401 

David Powell 
RAND Corporation, Arlington, VA 22202 

Bradley D. Stein 
RAND Corporation, Pittsburgh, PA 15213 

Terry Schell 
RAND Corporation, Santa Monica, CA 90401 

Rosalie Liccardo Pacula  
University of Southern California, Los Angeles, CA 90089 

Corresponding Author:  
Beth Ann Griffin 
1200 South Hayes Street 
Arlington, VA 22202 
bethg@rand.org 
703.413.1100, x5188 

arXix.com Version 
posted June 8, 2021 

1 

 
  
  
  
 
 
 
 
 
  
  
 
 
 
 
Abstract  
Background: Evaluations of state-level policies are central for identifying effective policies and 
informing policymakersâ€™ decisions. State-level policy evaluations commonly employ a 
difference-in-differences (DID) study design; yet within this framework, statistical model 
specification varies notably across studies. More guidance is needed about which set of statistical 
models perform best when estimating the impacts of state-level policies on outcomes.  
Methods: Motivated by applied state-level opioid policy evaluations, we implemented an 
extensive simulation study to compare the statistical performance of multiple variations of the 
two-way fixed effect models traditionally used for DID under a range of simulation conditions. 
We also explored the performance of autoregressive (AR) and GEE models. We simulated policy 
effects onto annual state-level opioid mortality rates and assessed statistical performance using 
various metrics, including directional bias, magnitude bias, and root mean squared error. We also 
report Type I error rates and the rate of correctly rejecting the null hypothesis (e.g., power), given 
the prevalence of frequentist null hypothesis significance testing in the applied literature. 
Results: While most linear models resulted in minimal bias, non-linear models and population-
weighted versions of classic linear two-way fixed effect and linear GEE models yielded 
considerable bias (60 to 160%).  Further, root mean square error was minimized by linear AR 
models when examining crude mortality rates and by negative binomial models when examining 
raw death counts. In the context of frequentist hypothesis testing, many models yielded high 
Type I error rates and very low rates of correctly rejecting the null hypothesis (< 10%), raising 
concerns of spurious conclusions about policy effectiveness in the opioid literature. When 
considering performance across models, the linear AR models were optimal in terms of 
directional bias, root mean squared error, Type I error, and correct rejection rates. 
Conclusions: The findings highlight notable limitations of commonly used statistical models for 
DID designs, designs widely used in opioid policy studies and in state policy evaluations more 
broadly. In contrast, the optimal model identified (the AR model) is rarely utilized in state-policy 
evaluation. We urge applied researchers to move beyond the classic DID paradigm and adopt the 
use of AR models.  

Key  words:  difference-in-differences;  state-level  policy;  policy  evaluations;  opioid;  overdose; 
simulation 

arXix.com Version 
posted June 8, 2021 

2 

 
 
 
 
 
1. BACKGROUND  
Evaluations of state-level policies are central to identifying effective policies and informing 
policymakersâ€™ decisions, yet the methodological rigor of published studies varies (see Schuler, 
Heins (1) for a review of the opioid policy literature). State-level policy evaluations commonly 
employ a difference-in-differences (DID) study design; yet within this framework, statistical 
model specification varies notably across studies. The choice of model specification as well as 
other factors â€“ including low outcome occurrence rates (e.g., opioid mortality), sample size (both 
the number of policy states as well as the number of time points available), and differences 
across states prior to policy adoption â€“ can impact the accuracy and precision of effect estimates. 
Although numerous publications provide analytic guidance for policy evaluations using 
longitudinal data (2-6) methodological best practices have not been fully adopted by applied 
researchers. Furthermore, there have been no comprehensive examinations of the relative 
performance of commonly used statistical models under conditions that mimic those encountered 
in actual state policy evaluation settings. 

A DID study design, broadly defined, has become dominant in the health care policy 

literature when using longitudinal data to evaluate the impact of state-level policies (7, 8). A DID 
design compares the outcomes observed among a group exposed to the policy of interest 
(treatment group) and an unexposed comparison group both across timepoints prior to policy 
implementation (first difference) and after policy implementation (second difference) â€“ the 
policy effect is estimated as the difference between the first and second differences, hence 
â€œdifference-in-differencesâ€ (7). However, a growing number of studies highlight challenges and 
limitations of a DID design, particularly when the key DID assumptions do not hold (4, 7, 9-11) 
or when sample size is limited (12). Additionally, it has been well-established that standard error 
corrections that adjust for violations of the assumed independence of the repeated measures in 
longitudinal datasets are needed to obtain accurate Type I error rates (13-17). Despite the wealth 
of knowledge concerning challenges of and best practices for DID designs in various settings, the 
applied literature largely does not reflect these insights (18-21).  

With the aim of promoting adoption of more robust statistical methods in health policy 
research, the present study empirically compares the performance of multiple variations of the 
two-way fixed effect model traditionally used in the context of a DID design for state-level 
policy evaluation. Our motivating context is the ongoing U.S. opioid crisis, which claimed over 
50,000 lives in 2019 alone (22) and has spurred states to adopt a myriad of opioid-related 
policies and initiatives. The urgency of the opioid crisis necessitates that accurate, robust 
statistical methods are utilized to identify effective state policies, yet our recent review of the 
â€œstate of the scienceâ€ of the opioid-policy literature highlighted that methodological rigor varied 
notably across studies (1). Applied researchers would benefit from additional, accessible 
guidance regarding the multitude of analytic choices both in the context of opioid-policy 
evaluations and state-level policy evaluations more generally. We are aware of only one other 
study considering relative performance across statistical methods in the context of health policy â€“ 
that study compared analytic approaches for evaluating state gun policy laws on gun-related 
mortality, another high-stakes health policy setting (19). While in some ways the settings are 
similar in terms of longitudinal state-level outcomes, the conclusions may differ due to 
differences in the underlying outcome distributions (e.g., opioid related mortality is more highly 
skewed outcome than total firearm deaths).    

The present study seeks to provide needed guidance about which set of statistical models 
commonly used in evaluations of state-level opioid policies with a DID study design perform 

arXix.com Version 
posted June 8, 2021 

3 

best when estimating the impacts of state-level opioid policies on opioid-related mortality, with 
lessons that most likely apply to state policy evaluations more broadly. Using a simulation study 
based on observed state-level opioid mortality, we assessed statistical performance using various 
metrics, including directional bias, magnitude bias, and root mean squared error; we additionally 
report Type I error and the rate of correctly rejecting the null hypothesis, given the prevalence of 
frequentist null hypothesis significance testing (NHST) in the applied literature. Our findings 
indicate that some commonly-used methods have poor statistical performance, which has 
implications for interpreting the existing literature as well as conducting rigorous future 
evaluation studies. Our discussion provides important insights to statisticians and researchers 
regarding methods to estimate policy effects, and highlights that there is still methodological 
development needed to address the challenges of rigorous policy effect estimation in the context 
of complex policy settings.  

2. METHODS 
The data structure, simulation conditions, empirical models considered in our simulation 

study are detailed below.  

2.1 Data Structure  

The data structure we considered in this study was longitudinal, repeated annualized 
measures at the state level. The outcome considered was opioid-related mortality, measured 
annually in each state over 18 years, providing 50*18=900 total observations, clustered within 
states. We did not consider the existence of individual-level data within the aggregate state level 
data. 

2.2 Empirical Models Considered 

The focus of our simulation study was to compare performance of multiple statistical models 
for estimating policy impact using annual state-level outcomes, given a policy landscape in which 
states implemented a given policy at different times. We compare the classic two-way fixed effects 
DID model to three additional models, selected based both on the previous gun policy simulation 
study (19) as well as a review of methods commonly used in opioid policy evaluations (1). 
Specifically, we consider: (1) a â€œdetrendedâ€ extension of the classic DID model that includes 
state-specific linear slopes; (2) a one-period lagged autoregressive (AR) model; and (3) 
generalized estimating equations (GEE) with an autoregressive correlation structure.   

) if the policy was in effect at time t while 

To formalize the setting and inferential goal, we use potential outcomes notation for repeated 
measures data such that 
 denotes the potential outcome (e.g., opioid-related mortality rate) for 
state i (
 denotes the potential outcome 
for state i if the policy was not in effect at time t. Thus, each state has two potential outcomes at 
each time point, representing the outcomes that would be achieved with and without the policy in 
effect. Our primary treatment effect of interest is E[
times, with each state and each time point equally weighted. Let 
for whether or not state i had the policy in effect at time t (where 

, averaging across both states and 

 {0,1} denote an indicator 

ð‘–ð‘– = 1, â€¦ ,50

ð‘Œð‘Œ1 âˆ’ ð‘Œð‘Œ0]

). Then, 

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–1

 denotes the observed outcome for state i at time t as measured 
=
longitudinally for state i over time 
 ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–1 âˆ— ð´ð´ð‘–ð‘–ð‘–ð‘– + ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0 âˆ— (1 âˆ’ ð´ð´ð‘–ð‘–ð‘–ð‘–)
Essentially, classic DID estimation compares the pre-policy to post-policy change in the 
treated group to the corresponding pre-period to post-period change in the comparison group. 
This difference-in-differences provides an estimate of the average policy effect, while controlling 
for time-invariant differences between treated and untreated states and for time-varying 

ð‘¡ð‘¡ = 1, â€¦ , ð‘‡ð‘‡. 

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

ð‘œð‘œð‘œð‘œð‘œð‘œ

ð´ð´ð‘–ð‘–ð‘–ð‘– =
ð‘¡ð‘¡ = 1, â€¦ , ð‘‡ð‘‡

arXix.com Version 
posted June 8, 2021 

4 

 
 
 
exogenous factors (i.e., those that affect both treated and untreated states equally). The classic 
DID specification is generally implemented as a two-way fixed effects model that includes both 
state- and time-fixed effects, expressed as: 

                                                  (1) 

 denotes the generalized linear model (GLM) link function (e.g., linear, log), 

ð‘œð‘œð‘œð‘œð‘œð‘œ

ð‘”ð‘”(. )

ð‘”ð‘”ï¿½ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

ï¿½ = ð›¼ð›¼ âˆ™ ð´ð´ð‘–ð‘–ð‘–ð‘– + ðœ·ðœ· âˆ™ ð‘¿ð‘¿ð‘–ð‘–ð‘–ð‘– + ðœŒðœŒð’Šð’Š + ðœŽðœŽð‘–ð‘– + ðœ€ðœ€ð‘–ð‘–ð‘–ð‘–

where 
denotes a vector of time-varying state-level covariates and 
effects, 
quantify temporal national trends. The coefficient estimate 
namely the policy effect of 
not implementing a policy and time trends.  

ðœ€ðœ€ð‘–ð‘–ð‘–ð‘–

ðœŒðœŒð‘–ð‘–

ð‘Žð‘Žï¿½

, quantify potential differences in the outcome across states, and time fixed effects, 

  denotes the error term. State fixed 
, 

ð‘¿ð‘¿ð‘–ð‘–ð‘–ð‘–

 represents the DID estimator, 

ðœŽðœŽð‘–ð‘–
 after accounting for differences between states implementing and 

ð´ð´

Standard DID models assume that the difference in the outcomes of the treated and untreated 
groups would remain constant in the absence of the policy intervention (with magnitude equal to 
that observed pre-policy). In practice, this assumption is often referred to as the â€œparallel trendsâ€ 
assumption, although we note that â€œparallelismâ€ is actually a stronger assumption than necessary, 
as trajectories need only be equivalent, not necessarily parallel in the linear sense (23). The 
outcome levels themselves are not assumed to be equivalent across groups; level differences are 
accounted for by the state fixed effects. A common misperception is that this assumption can be 
tested by assessing whether pre-policy period trends are parallel; however, this assumption is 
inherently untestable as it involves the unobservable counterfactual trends in the post-period. 
Indeed, conducting â€œtests of parallel trendsâ€ in the pre-period can lead to bias and misleading 
results (23).  

The second model that we evaluate is an extension of the classic DID model that additionally 
includes state-specific slopes (referred to as â€œdetrendingâ€ the data). The detrended model can be 
expressed as: 

          (2) 

ï¿½ðœ”ðœ”ð‘œð‘œ âˆ™ ð‘¡ð‘¡ âˆ™ 1(ð‘ ð‘ ð‘¡ð‘¡ð‘Žð‘Žð‘¡ð‘¡ð‘ ð‘ ð‘–ð‘– =

 denotes the state-specific linear slope over time and 
where 
+ ðœðœð‘–ð‘–ð‘¡ð‘¡
model expands on Equation (1) by adding in state-specific linear trends 

ï¿½ =  ð›¼ð›¼ âˆ™ ð´ð´ð‘–ð‘–ð‘¡ð‘¡ + ðœ·ðœ· âˆ™ ð‘¿ð‘¿ð‘–ð‘–ð‘¡ð‘¡ + ðœŒðœŒð’Šð’Š + ðœŽðœŽð‘¡ð‘¡ + âˆ‘ (ðœ”ðœ”ð‘ ð‘  âˆ™ ð‘¡ð‘¡)

ð‘”ð‘”ï¿½ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

ð‘œð‘œð‘œð‘œð‘œð‘œ

50
ð‘ ð‘ =1

 denotes the error term. This 

ðœ”ðœ”ð‘œð‘œ
. In this model, each state has its own fixed effect to account for its mean as well as a 

ðœðœð‘–ð‘–ð‘–ð‘–

unique linear slope over time. Because the model also includes a national time trend (fit via year 
ð‘ ð‘ ð‘¡ð‘¡ð‘Žð‘Žð‘¡ð‘¡ð‘ ð‘ ð‘œð‘œ)ï¿½
fixed effects), the state-specific linear trend is interpreted as the difference between the national 
time trend and the state trend. This model may be used as a robustness check to rule out 
differential state trajectories over time â€“ i.e., if Equations (1) and (2) yield similar policy effects, 
this suggests the absence of differential trajectories (see Bilinski and Hatfield (23) for a 
discussion of this approach). In the presence of differential trajectories that are additive, 
Equation (2) should offer an improvement over Equation (1). However, caution must be used, as 
the time trend terms may functionally "over control" and absorb part of the treatment effect in 
addition to pre-existing differential trends, particularly in the presence of a time-varying 
treatment effect (24).  

Additionally, we considered an AR model, as the prior gun policy simulation study found 
that AR models performed especially well when estimating the policy effect on total firearms 
deaths (17). AR models include one or more lagged measures of the outcome (e.g., 
covariates to control for potential average differences in outcome trends across treated and 
comparison states. These models can improve prediction when outcomes are highly 
autocorrelated, as is the case with annual measures of state-level opioid-related mortality. The 
AR model examined here included a single lagged value of the outcome (as this was identified as 
the top performing AR model in the prior gun policy simulation study), expressed as: 

ð‘œð‘œð‘œð‘œð‘œð‘œ
ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–âˆ’1

) as 

arXix.com Version 
posted June 8, 2021 

5 

 
                                   (3) 

ð‘œð‘œð‘œð‘œð‘œð‘œ

ð‘”ð‘”(ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

Akin to Equation (1), this model includes time fixed effects, 
,  to quantify temporal trends 
ð‘œð‘œð‘œð‘œð‘œð‘œ
+ ðœŽðœŽð‘–ð‘– + ðœ–ðœ–ð‘–ð‘–ð‘–ð‘–
) = ð›¼ð›¼ âˆ™ (ð´ð´ð‘–ð‘–ð‘–ð‘– âˆ’ ð´ð´ð‘–ð‘–,ð‘–ð‘–âˆ’1) + ðœ·ðœ· âˆ™ ð‘¿ð‘¿ð‘–ð‘–ð‘–ð‘– + ð›¾ð›¾ âˆ™ ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–âˆ’1
across time, but adjusts for state-specific variability through the use of the AR term (
) 
ðœŽðœŽð‘–ð‘–
rather than state fixed effects. Notably, inclusion of the AR term creates a â€œchangeâ€ model, as 
ð‘œð‘œð‘œð‘œð‘œð‘œ
ð›¾ð›¾ âˆ™ ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–âˆ’1
the policy effect is defined as the expected difference in the outcome, given the prior yearâ€™s 
outcome. As such, we coded the policy variable (A) using change coding 
on early work demonstrating that effect size estimates from AR models can be substantially 
 (25). An AR model with a single lagged outcome 
biased when using standard effect coding 
is very closely related to the first-difference estimator, a commonly-used alternative to the fixed 
(ð´ð´ð‘–ð‘–ð‘–ð‘–)
effects estimator (e.g., Equation (1)). Indeed, when there are only 2 time periods, a first-
difference estimator and fixed effects estimator are identical; with 3 or more time periods, the 
relative performance of these estimators depends on the degree of autocorrelation in the outcome 
(18, 26). 

(ð´ð´ð‘–ð‘–ð‘–ð‘– âˆ’ ð´ð´ð‘–ð‘–,ð‘–ð‘–âˆ’1)

, based 

Finally, we considered a fixed effect model using GEE. In the context of correlated outcomes 

(e.g., within states), GEE model parameters are estimated by specifying a covariance structure 
for the clustered outcomes (27). This model can be expressed as: 

                                                 (4) 

ð‘œð‘œð‘œð‘œð‘œð‘œ

which includes time fixed effects 
. 
ï¿½ = ð›¼ð›¼ âˆ™ ð´ð´ð‘–ð‘–ð‘–ð‘– + ðœ·ðœ· âˆ™ ð‘¿ð‘¿ð‘–ð‘–ð‘–ð‘– + ðœŽðœŽð‘–ð‘– + ðœðœð‘–ð‘–ð‘–ð‘–,
GEE is a semi-parametric method that requires specification of the covariance matrix for within-
subject observations (e.g., exchangeable, autoregressive, unstructured). We assume an 
autocorrelation structure of order 1 (AR1) which means the correlation structure R for the 
repeated measures within each state is 

 and time-varying state-level confounders measured in 

ð‘”ð‘”ï¿½ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

ð‘¿ð‘¿ð‘–ð‘–ð‘–ð‘–

ðœŽðœŽð‘–ð‘–

|ðœŒðœŒ

ð‘…ð‘…ð‘–ð‘–,ð‘šð‘š = ï¿½

| ð‘–ð‘–ð‘–ð‘– ð‘¡ð‘¡ â‰  ð‘šð‘š

for the t, m element of R.  

1 ð‘–ð‘–ð‘–ð‘– ð‘¡ð‘¡ = ð‘šð‘š
ð‘–ð‘–âˆ’ð‘šð‘š
Overall, in the context of a longitudinal policy evaluation study, the central challenge is 
disentangling what degree, if any, of the observed heterogeneity in outcomes across states is due 
to a true policy effect versus other factors. All models we considered included time fixed effects 
to account for state-invariant (i.e., national) temporal trends. Additionally, the classic DID and 
detrended DID both included state fixed effects in order to reduce bias due to time-invariant 
factors that vary across states. In contrast to fixed effects, the autoregressive model adjusts for 
state-specific variability through the use of the lagged outcome term and a GEE approach uses an 
AR correlation structure to account for correlation at the state-level. The optimal model should 
be the one for which the underlying assumptions of the model match the true processes 
generating the data. As it is impossible to test model assumptions in practice, we used a 
simulation study with a known data-generating process to assess the relative performance of 
these statistical models.  

2.3 Statistical Models Tested via Simulation 

Within our four primary DID variations (i.e., classic two-way fixed effect model, detrended 
model, autoregressive model, and GEE model), we additionally considered three other estimation 
aspects: GLM link function specification, standard error estimation, and weighting to account for 
state population. We detail each below and summarize all candidate models in Table 1.  

arXix.com Version 
posted June 8, 2021 

6 

 
 
Table 1. Overview of statistical models evaluated in simulation study 

Regression 
specification 

Classic 2-way 
Fixed Effects 

Detrended 

Autoregressive 

GEE 

Link function 

SE estimation 

Population weighting 

Linear 

none; Huber; cluster 

Population weighted; unweighted 

Log-linear 
Negative 
Binomial 
Poisson 
Linear 
Negative 
Binomial 
Linear 
Log-linear 
Negative 
Binomial 
Poisson 
Linear 

none; Huber; cluster 

Population weighted; unweighted 

none; Huber; cluster 

Unweighted, with log(population) used as an offset 

none; Huber; cluster 
none; Huber; cluster 

Unweighted, with log(population) used as an offset 
Population weighted; unweighted 

none; Huber; cluster 

Unweighted, with log(population) used as an offset 

none; Huber; cluster 
none; Huber; cluster 

Population weighted; unweighted 
Population weighted; unweighted 

none; Huber; cluster 

Unweighted, with log(population) used as an offset 

none; Huber; cluster 
AR1 structure 

Unweighted, with log(population) used as an offset 
Population weighted; unweighted 

(1) GLM specifications: As opioid-related deaths are discrete and historically rare events, count 
models or models accounting for the skewed nature of the outcome may be more appropriate 
than traditional linear models assuming normality. We tested the relative performance of the 
following GLMs:  linear, log-linear (a linear model with log-transformed outcome), and two 
log-link models (negative binomial and Poisson).  

(2) Standard error (SE) estimation: There are 3 commonly used ways to estimate the SE of the 
effect estimate: (1) no adjustment; (2) Huber adjustment: robust estimators (also known as 
sandwich estimators, or Huber corrected estimates) that attempt to adjust the SE for 
violations of distributional assumptions (28, 29); and (3) cluster adjustment: adjustments to 
account for possible violations of the assumed independence of observations within states 
(28-30). For each model (except the GEE model), we estimated the SE in these three ways. For 
the GEE models, we used the AR(1) covariance structure for our SE estimation. We also note 
that we additionally considered the Arellano method (31) as implemented in Râ€™s vcovHC 
package, yet do not report these results for parsimony, as they were very similar to the Huber 
method (see our Shiny tool for full details). 

(3) Use of state population weights: Finally, we explored the impact of using state population 
as an analytic weight in the linear and log-linear models, an approach commonly used in 
state-level policy evaluations (e.g., within opioid-related policy studies (32-35)), For state-
level analyses of opioid-mortality rates, the use of population weights puts equal weight on 
each death, regardless of which state it occurred in, whereas unweighted analyses put equal 
weight on each state, such that a death in a small state will have much greater weight than a 
death in a larger state. We note that data was generated such that policy effects are constant 
across all states regardless of size or other characteristics, so weighting is not expected to 
affect bias but may have substantial effects on the SE estimates. Given that log-link models 
(e.g., negative binomial, Poisson) are estimated using mortality counts (rather than rates) 
and do not need to be weighted to be nationally-representative, we did not examine the 
impact of weighting in these models. Instead, these models include the logarithm of state 
population size as an offset, resulting in a model that is effectively predicting the opioid-
related death rate, such that exponentiated model coefficients can be interpreted as incident 
risk ratios. 

arXix.com Version 
posted June 8, 2021 

7 

 
 
 
 
 
 
 
 
 
3. SIMULATION DETAILS 
This section describes our simulation study in detail, including the data sources used in the 
study, the data generation scheme, and the performance metrics used to compare the approaches. 

3.1 Data Sources and Measures 

The outcome of interest is the annual state-specific opioid mortality rate per 100,000 state 
residents, obtained from the 1999-2016 National Vital Statistics System (NVSS) Multiple Cause 
of Death mortality files. Consistent with other studies (36-38), opioid related overdose deaths 
were identified based on ICD10-CM-external cause of injury codes X40-X44, X60-64, X85, and 
Y10-Y14, indicating accidental and intentional poisoning, with opioid overdose based on the 
presence of one of the following diagnosis codes: T40.1 poisoning by heroin, T40.2 poisoning by 
natural and semisynthetic opioids (e.g., oxycodone, hydrocodone), T40.3 poisoning by 
methadone, and T40.4 poisoning by synthetic opioids excluding methadone (e.g., fentanyl, 
tramadol).  

Given concerns about model overfitting in the presence of numerous covariates (39), we 
included only a single covariate: state-level unemployment rate (40). This covariate was selected 
because of the frequency of its use in opioid policy studies (1). Sensitivity analyses including a 
broader set of covariates (e.g., poverty rates, income levels, and percentages in defined 
race/ethnicity and age groups) resulted in no meaningful change to the general findings with a 
slight increase in precision; as such, we present findings from the more parsimonious model.  

3.2 Simulation Data Generation 

The simulation design builds directly from prior work that compared statistical methods for 
evaluating the impact of state laws on firearms deaths (19). For each simulation iteration, 5,000 
simulated datasets were generated.  

In each simulated dataset, a random subset of k states were selected to be the policy/treated 
group, with remaining states serving as the comparison/untreated. This simulation represents the 
simplified scenario in which there is no confounding by observed or unobserved covariates or by 
lagged values of the outcome, 
generated to denote whether the hypothetical policy was in effect. For comparison states, 
for the entire study period. For policy states, the month and year of policy enactment were 
randomly generated, with year restricted to 2002-2013 (inclusive) to ensure at least three years of 
it was coded as 
outcome data both before and after enactment. In the first year of implementation, 
fractional value between 0 and 1, indicating the percentage of the year the policy was in effect. Once a 
policy was implemented, it remained in effect throughout the study period; thus, 
remaining years. 

. For each state and year, a time-varying indicator 

ð´ð´
it = 1 for all 

ð‘œð‘œð‘œð‘œð‘œð‘œ
ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–âˆ’1

it was 

it = 0 

ð´ð´

ð´ð´

ð´ð´

As we were considering models with different log links, we evaluated their performance using 
simulated data for which each model was correctly specified, so as to facilitate comparison across 
models. Simulated outcome data were generated as follows: For untreated states, outcome values 
were set equal to the actual observed state-specific, year-specific opioid overdose rates for all 
times t, namely 
equal to the actual observed values 
ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–
outcomes 
magnitude 
linear models; and 

 were generated by augmenting the observed value 
ð‘œð‘œð‘œð‘œð‘œð‘œ
for linear models; 
 as follows: 

. For treated states in the post-policy period, 

. Similarly, for treated states in the pre-policy period, values are also 

 â€“ 1) for log link models.  

 with an effect size of 

= ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0)

 for log-

= ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0

(ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

ð‘œð‘œð‘œð‘œð‘œð‘œ

*(
Simulation conditions varied the following factors: 

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–1 = ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0 + ð›¼ð›¼ð‘™ð‘™ð‘–ð‘–ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ 

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0
ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–1 = ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0

+ logï¿½ð›¼ð›¼ð‘™ð‘™ð‘œð‘œð‘™ð‘™ï¿½

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–1
ð›¼ð›¼

ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–1 = ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0

ð›¼ð›¼ð‘™ð‘™ð‘œð‘œð‘™ð‘™

arXix.com Version 
posted June 8, 2021 

8 

 
 
 
(1) Effect size. We considered settings when the policy had a null effect, as well as a non-null 

,

 = 0), post-policy 

, for both treatment groups. 

 with respect to link function 
) to ensure that the magnitude of the resulting effect, calculated in terms of 

effect of small, medium and large magnitude. For null effect conditions
observations were equal to actual observed values
When generating non-null effects, we tailored the magnitude of 
= ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–0
(i.e., 
the mean number of additional deaths nationally (per 100,000 people), was comparable 
across models. Specifically, we started by generating data with an 
(medium), and Â±25% (large) on the multiplicative scale and then empirically calculated the 
average excess mortality count across simulated datasets for each effect size. We then 
specified the corresponding 
effect size of the same magnitude (i.e., 

values for the linear models such that they would yield an 
= Â±0.23, Â±0.70, and Â±1.16). 

= Â±5% (small), Â±15% 

ð›¼ð›¼ð‘™ð‘™ð‘–ð‘–ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™

 ð›¼ð›¼ð‘™ð‘™ð‘œð‘œð‘™ð‘™

ð›¼ð›¼ð‘™ð‘™ð‘œð‘œð‘™ð‘™ 

, ð‘Œð‘Œð‘–ð‘–ð‘–ð‘–

 (ð›¼ð›¼

ð‘œð‘œð‘œð‘œð‘œð‘œ

ð›¼ð›¼

(2) Number of treated units. We also investigated the role of the number of policy states, 

ð›¼ð›¼ 

simulating data in which 1, 5, 15 and 30 states implemented the policy. Note that the total 
sample size of treated and untreated states is always 50. 

ð›¼ð›¼ð‘™ð‘™ð‘–ð‘–ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™ð‘™

(3) Timing of policy effect. State policies often do not become 100% effective immediately after 

implementation, making it important to consider variation in the onset of policy 
effectiveness. We considered two possible conditions: an instantaneous effect and a 3-year 
linear phase-in effect. In both the data generating and analytic models, an instantaneous 
effect was specified as a simple step-function that has a value of zero when the policy is not 
in effect and a value of one when the policy is in effect (as described above). The gradual 
policy effect allows for the effect of the policy to grow linearly in the first 3 years after 
implementation with values starting at zero and reaching 1 after 3 years of implementation. 

3.3 Metrics for Assessing Relative Performance of Candidate Statistical Methods 

Performance metrics include directional bias, magnitude bias, and root mean squared error, as 

well as Type I error and rate of correctly rejecting the null hypothesis, given the prevalence of 
frequentist NHST in the applied literature.  
(1) Directional bias. Directional bias assesses the average difference between the estimated 
effect and true effect over all simulations for a given effect size (e.g., Â±5%), showing the 
tendency of the estimated effects from a given model to fall closer or further from the true 
effect on average. We report directional bias summarized over both the positive effect size 
conditions (e.g., +5%) as well as the negative effect size conditions (e.g., -5%) to quantify 
how the models are doing on average for a fixed effect size
define directional bias as the average of the sum of the bias across positive and negative 
effect simulations, as follows: 

 ð›¼ð›¼

, regardless of the direction. We 

ð·ð·ð‘–ð‘–ð·ð·ð‘ ð‘ ð·ð·ð‘¡ð‘¡ð‘–ð‘–ð‘œð‘œð‘œð‘œð‘Žð‘Žð‘œð‘œð‘œð‘œð‘–ð‘–ð‘Žð‘Žð‘ ð‘ ð›¼ð›¼ =   ï¿½âˆ‘

Additionally, we standardized bias by reporting it with respect to the mortality count for both 
linear and nonlinear models to facilitate comparison across models. Then, we converted the 
standardized directional bias into percent directional bias by dividing it by the expected 
change in mortality count that corresponds to the given 
change in deaths nationally will equal Â±700, respectively). 

 = Â±5% the expected 

5000 + âˆ‘

 (e.g., when 

ï¿½ /2

5000

5000
ð‘˜ð‘˜=1

5000
ð‘˜ð‘˜=1

ð›¼ð›¼ï¿½ð‘˜ð‘˜,ð‘ð‘ð‘ð‘ð‘ð‘âˆ’ð›¼ð›¼ð‘ð‘ð‘ð‘ð‘ð‘

ð›¼ð›¼ï¿½ð‘˜ð‘˜,ð‘›ð‘›ð‘›ð‘›ð‘›ð‘›âˆ’ð›¼ð›¼ð‘›ð‘›ð‘›ð‘›ð‘›ð‘›

(2) Magnitude bias. Magnitude bias assesses whether the estimated effects are systematically 
too small or too large, relative to the true effect. Magnitude bias is computed by taking the 
average of the bias across the positive and negative effect simulations, after multiplying the 
bias from the negative effect simulations by negative one.  

ð›¼ð›¼

ð›¼ð›¼

arXix.com Version 
posted June 8, 2021 

9 

 
  
ð›¼ð›¼ï¿½ð‘˜ð‘˜,ð‘ð‘ð‘ð‘ð‘ð‘âˆ’ð›¼ð›¼ð‘ð‘ð‘ð‘ð‘ð‘

ð›¼ð›¼ï¿½ð‘˜ð‘˜,ð‘›ð‘›ð‘›ð‘›ð‘›ð‘›âˆ’ð›¼ð›¼ð‘›ð‘›ð‘›ð‘›ð‘›ð‘›

5000
ð‘˜ð‘˜=1

5000
ð‘˜ð‘˜=1

5000 âˆ’ âˆ‘

ð‘€ð‘€ð‘Žð‘Žð‘”ð‘”ð‘œð‘œð‘–ð‘–ð‘¡ð‘¡ð‘€ð‘€ð‘€ð‘€ð‘ ð‘ ð‘œð‘œð‘–ð‘–ð‘Žð‘Žð‘ ð‘ ð›¼ð›¼ = ï¿½âˆ‘

For example, with a model that shows a magnitude bias of +0.1 with a true effect size of 
Â±0.30, the model typically gives estimates of +0.4 or â€“0.4 for the positive and negative 
effect versions of the simulation, respectively, exaggerating the true effect size in both 
cases. Conversely, a model that shows a magnitude bias of -0.1 would give estimates of 
+0.3 or â€“0.2 for the positive and negative effect simulation, respectively, underestimating 
the true effect size. As with directional bias, we standardized magnitude bias so it 
represents mortality count and report percent magnitude bias below by dividing it by the 
corresponding expected change in deaths nationally that would correspond to the given 

ï¿½ /2

5000

(3) Root mean squared error (RMSE). RMSE is calculated by taking the square root of the sum 
ð›¼ð›¼.

of the mean squared errors (e.g., 

 ). RMSE quantifies error for a 

5000
ð‘˜ð‘˜=1

2

given model specification, taking into account both directional bias and variance.  
(4) Type I error rate. In the context of traditional NHST, Type I error rate is the frequency of 
incorrectly rejecting the null hypothesis (i.e., there truly is no policy effect). When data are 
generated such that there is no true policy effect (i.e., the null  hypothesis is true), the model 
should identify a statistically significant effect (i.e., reject the null  hypothesis) no more than 
5% of the time if tested with an 0.05 level of significance. 

(ð›¼ð›¼ï¿½ð‘˜ð‘˜ âˆ’ ð›¼ð›¼)

/5000

ï¿½âˆ‘

(5) Correct NHST rejection rates. We also assessed the ability of the model to correctly identify that 
the null hypothesis is false in the context of traditional NHST. We quantify the â€œrate of correct 
rejectionsâ€ for each model by calculating the proportion of estimates that were both 
statistically significant and in the same direction as the true effect. When conducting this 
significance test, we used a SE correction factor to ensure comparability of correct NHST 
rejection rates across models with the exact same Type I error rate. Without applying the SE 
correction factor, models that underestimate the true error in their estimates would appear to 
have excellent statistical correct rejection rates, even though the actual sampling variability 
in their estimates may be quite high, in which case the model may not actually be sensitive to 
detecting a true effect. Typically, analyses are considered to have adequate statistical correct 
rejection rates/power if the likelihood that they correctly reject the null hypothesis is 80% or 
higher. 

Simulations were conducted in R using the forthcoming OPTIC.simRM library; code is available in the 
appendix. Extensive results for all statistical models considered in our simulation are available via 
a Shiny tool (https://elizabethmcneer.shinyapps.io/statmodelsim/). 

4. RESULTS 
In each section below, we first compare results for the set of four linear models (i.e., linear 
two-way fixed effects, linear detrended, linear AR, and linear GEE models). We then discuss the 
relative performance across different GLMs (i.e., negative binomial, Poisson, and log-linear 
models). For parsimony, all summary statistics are averaged across simulation conditions with a 
gradual policy effect and an instantaneous policy effect.  

4.1. Directional bias 

Figure 1 shows percent directional bias as a function of both effect size magnitude and the 

number of policy states for the four different linear models (using population weights). In all 
cases, percent directional bias decreased both as effect size increased and the number of policy 
states increased. Most notably, the linear two-way fixed effects model (the classic DID model) 

arXix.com Version 
posted June 8, 2021 

10 

  
 
 
 
had high percent directional bias when the number of treated states was lower than 15 (e.g., 
ranged from 22% to 291%) (Figure 1a). The linear GEE had similar directional bias to the linear 
two-way fixed effects (ranged from 0% to 305%) (Figure 1d). Directional bias was much lower 
for the detrended model and AR models compared to the two-way fixed effects and GEE models 
(ranging from Â±3% to -21%) (Figures 1b and c).  

Figure 2 shows the percent directional bias for all models under the small effect size 
condition. Notably, the majority of models had positive directional bias suggesting estimated 
effects tend to be numerically larger in a positive way on average, regardless of the direction of 
the true policy effect. The large majority of models had very high rates of directional bias. For 
example, non-linear models yielded directional bias ranging from 64% to 162%, which translates 
into excess mortality estimates that are off by 448 to 1,134 more deaths. Directional bias was 
smallest in the linear models (ranging from -2% to -12%), with the exception of the weighted 
linear two-way fixed effects and weighted GEE models where directional bias was quite large 
(116% and 109%, respectively).  

The directional bias was relatively similar between weighted and unweighted versions of 
both the linear AR and linear detrended models. In contrast, directional bias was significantly 
larger for weighted  version, compared to the unweighted version, for both the traditional DID 
model (unweighted=-2%; weighted=109%) and linear GEE model (unweighted=-3%; 
weighted=116%). Further, directional bias was notably larger when there was a gradual versus 
an instantaneous policy effect, although the magnitude of this difference varied by model.  

4.2. Magnitude bias 
  Broadly, as seen with directional bias, magnitude bias decreased as both effect size and 
number of policy states increased. We present magnitude bias results for all models under the 
small effect size condition (Figure 3). Magnitude bias was less than 10% for most models, with 
the exception of the four non-linear AR models (14-25% for the negative binomial, Poisson, and 
log-linear AR models). Most of the models with non-zero magnitude bias had positive magnitude 
bias (i.e., overestimating the true policy effect), ranging from 4% (negative binomial 2-way fixed 
effects and detrended models) to 25% (Poisson AR model). In contrast, the linear AR model had 
negative magnitude bias (i.e., underestimating the true policy effect), ranging from -4% (with 
population weights) to -2% (no population weights). For each GLM type, magnitude bias was 
greater for the AR model compared to the two-way fixed effect or detrended models.  

The use of population weights in the linear and log-linear models did not consistently or 
notably influence magnitude bias. Furthermore, the magnitude bias remained essentially 0% for 
the linear two-way fixed effects, linear GEE, and linear detrended models for both the gradual 
and instantaneous policy effect conditions. For all the other models, magnitude bias was 
consistently higher for the gradual versus the instantaneous effect conditions (e.g., for the 
negative binomial AR model, magnitude bias was 10% for the instantaneous condition and 23% 
for the gradual condition). 

4.3 Root mean square error 

Figure 4 shows the average RMSE for simulation conditions with a null treatment effect. 
Among linear models, AR models had the lowest RMSE (1.08-1.12) compared to the two-way 
fixed effects models (1.67-1.78), detrended models (1.63-1.69), and GEE models (1.37-1.92) 
(Figure 4a). For the two-way fixed effects, detrended, and GEE models, RMSE was lower for 
the unweighted models than the corresponding weighted models; however, for the AR models, 

arXix.com Version 
posted June 8, 2021 

11 

 
 
 
 
 
 
 
population weighting yielded slightly lower RMSE. Among non-linear models, the negative 
binomial models had consistently lower RMSE compared to the Poisson and log-linear models 
(Figure 4b). For the negative binomial model, the detrended and two-way fixed effects models 
had the lowest RMSE (0.22) while the AR model had the highest RMSE (0.31). Finally, as 
expected, RMSE was larger for simulation conditions with a gradual policy effect relative to an 
instantaneous effect (e.g., for the linear population two-way fixed effects model, RMSE=1.58 for 
instantaneous and RMSE=1.95 for gradual).  

4.4 Type I error rates  

Figure 5 presents the Type I error rates for the four linear models (using population weights). 

Type I error rates were very high for the classic DID two-way fixed effects model (Figure 5a), 
ranging up to 67%. Cluster SE adjustment greatly reduced the Type I error rates for this model 
when 5 or more states implemented a policy, but they were still 2 to 3 times larger than the 
traditional target of 5%, ranging from 9% to 17%. The detrended model (Figure 5b) generally 
had slightly lower Type I error rates than the two-way fixed effects model, with Type I error 
rates mostly less than 40%. Notably, the AR model (Figure 5c) did not require use of any SE 
adjustment to obtain appropriate Type I error rates for conditions with 5 or greater policy states 
(e.g., Type I error rates ranged from 4% to 6%); in fact, SE adjustments in the AR models tended 
to inflate the Type I error rates. For linear GEE models (Figure 5d), Type I error rates were 18% 
or less for simulation conditions with at least 5 policy states, though rates were still 2-3 times 
higher than the traditional target of 5%. As in the case of linear models, AR models performed 
best, followed by detrended models, then two-way fixed effects models in the case of non-linear 
models (log-linear, Poisson, and negative binomial). 

For linear models, population weighting yielded slightly higher Type I error rates for the 
two-way fixed effects, detrended, and GEE models compared to the corresponding unweighted 
models (see Shiny Application). In contrast, for the AR models, population weighted models did 
not consistently perform better or worse than unweighted models. Additionally, Type I error 
rates were higher (by approximately 8 percentage points) for simulation conditions with a 
gradual relative to an instantaneous effect. 
  Given the top performance of the AR model, we also present the relative performance of the 
AR model across four different GLMs: linear (unweighted), log-linear (unweighted), Poisson, 
and negative binomial (Figure 6). Similar to the results seen for the linear AR weighted model 
(Figure 4), very good Type I error rates are obtained in the absence of SE adjustment for linear 
AR unweighted model, the log-linear AR unweighted model, and the negative binomial AR 
model, regardless of the number of policy states. We note that this does not hold for the Poisson 
AR model.  

4.5 Correct NHST rejection rates 

Figure 7 shows correct NHST rejection rates as a function of both the effect size and the 

number of policy states for the linear models (using population weights). In all cases, as 
expected, correct rejection rates increased both as the effect size increased and the number of 
policy states increased, with maximum values obtained for the simulation condition with 30 
policy states and a large effect size. For the two-way fixed effects model (Figure 7a), correct 
rejection rates were low across all effect sizes, with a maximum value of 27%. In contrast, 
correct rejection rates were highest for the AR model (Figure 7c), which achieved a maximum 
value of 73% (nearly the desired 80% rate). Relative to the two-way fixed effects model, correct 

arXix.com Version 
posted June 8, 2021 

12 

 
 
 
 
 
rejection rates were similar for the GEE model (maximum value=30%) and slightly higher for 
the detrended model (maximum value=41%). Importantly, all models considered had extremely 
low correct rejection rates for simulation conditions with a small effect size â€“ e.g., the rate of 
correctly rejecting the null hypothesis was 8% for negative binomial models and ranged from 4% 
to 11% across linear models. 

For linear and log-linear models, correct rejection rates tended to be higher for unweighted 
models relative to weighted models. Specifically, the linear two-way fixed effects model yielded 
a correct rejection rate of 40% for the unweighted model compared to 27% for the unweighted 
model for the simulation condition with 30 policy states and a large effect size. Similarly, the 
unweighted linear AR model yielded the correct rejection rate of 81% (compared to 72% for 
weighted) and the unweighted GEE model yielded the correct rejection rate of 67% (compared to 
30% for weighted). Correct rejection rates were consistently smaller (by 3 percentage points on 
average) for simulation conditions with a gradual relative to an instantaneous policy effect. 

Figure 8 presents correct rejection rates averaged across all simulation conditions in order to 
highlight relative performance across models. Correct rejection rates were low across all models 
but were highest for linear AR models (ranging from 22% to 24%) and negative binomial models 
(ranging from 20% to 23%). The worst performing models were the linear and log-linear two-
way fixed effects models and the linear weighted GEE model (correct rejection rates ranged from 
9% to 11%). Correct rejection rates for the Poisson models ranged from 12% (two-way fixed 
effects model) to 18% (AR model); we note that for all specification, the Poisson model was 
outperformed by the corresponding negative binomial model.  

5. DISCUSSION 

State-level policy evaluations commonly employ a DID study design; yet model specification 
varies notably across studies and the field lacks clear guidance on which models are optimal. We 
conducted a novel simulation study to compare the relative performance of multiple variations of 
the two-way fixed effect model traditionally used for DID, using simulated data based on actual 
national opioid mortality data so as to mirror data features encountered in practice. Specifically, 
we compared the classic, linear two-way fixed effects DID model to three alternative models: a 
detrended model, an AR model, and fixed effect model estimated with GEE with an AR 
correlation structure. Within these classes of models, we additionally compared link function 
specifications, SE estimation methods, and the use of population weighting. As discussed further 
below, we found that the linear AR model was optimal when the outcome was specified as a 
mortality rate and a negative binomial model was optimal when the outcome was specified as a 
mortality count. Despite being widely used in applied research, our results highlighted that two 
widely-used linear DID models â€“ two-way fixed effect and detrended â€“ were consistently 
outperformed by the less commonly-used AR linear model, which was consistently optimal in 
terms of directional bias, RMSE, Type I error, and power. As such, we urge applied researchers 
to move beyond the classic linear two-way fixed effect DID paradigm and consider the use of 
AR models. Overall, our results indicated notable differences in the performance of the models 
considered, which has substantial implications for the conduct and interpretation of state-level 
policy evaluations.  
  Results from the present study are highly consistent with findings from a prior gun policy 
simulation study (19), as both studies identified autoregressive models as a top performing model 
for estimating state-level policy effects. Given the consistency of these findings, it is likely that 
advantages of AR models over may generalize contexts beyond opioid- and firearm-related 

arXix.com Version 
posted June 8, 2021 

13 

 
 
 
mortality. The present study considers a broader range of simulation conditions than the prior 
gun policy study (e.g., a range of policy effect sizes (5% to 25%) compared to a single effect size 
(3%)), which similarly strengthens the generalizability of the results. However the optimal 
choice of the link function may vary by the characteristics of the outcome variable: the gun 
policy simulations study, which examined firearm-related mortality, found that the negative 
binomial AR model was optimal whereas the current study, which examined opioid-related 
mortality, identified the linear AR models as optimal. Indeed, the negative binomial AR model 
yielded much higher directional and magnitude bias (relative to the linear AR model), likely due 
to the greater relative skew in the distribution of state-level opioid-related deaths compared to 
firearm-related deaths. This suggests there is a benefit to running these types of simulations on 
specific outcomes to ensure selection of the final optimal model for a given outcome. We have 
an R library for executing these simulations on any repeated measures levels data 
(OPTIC.simRM).  
  We make recommendations for practice in Table 2. Although many of these results have been 
found by others, they have not been well appreciated in the statistical or applied literature, and 
questions have remained regarding best practices with real-world data like opioid-related 
mortality rates. For example, with regard to standard error corrections, prior simulation studies 
(13, 16) show that cluster adjustments are needed to reduce Type I error rates. Bertrand, Duflo 
(14) showed that the classic sandwich estimator does poorly with small samples; that paper also 
shows DID without adjustment has high Type I errors (approximately 45%) in their case study 
data where they randomly simulated random â€œplaceboâ€ laws, as done here. Our work extends 
prior work by highlighting the challenges specific to the context of evaluating state-level opioid 
policies with respect to opioid-related mortality, a widely-used outcome in the field.  

Table 2. Key Takeaways for the Practice 

When modeling opioid-related mortality as a crude rate in a linear model inclusion of an 
autoregressive term significantly improves estimation performance with regard to RMSE.  

When modeling counts of opioid-related mortality, a negative binomial model performs 
better than a Poisson model.  

Linear AR models performed optimally with respect to bias, RMSE, Type I error, and 
correct rejection rates in the context of estimating state-level policy effects of opioid-related 
mortality 

Sample size matters for SE estimation. For linear and log-linear models, clustered SEs 
significantly improved estimation when the treated group comprised 15+ states, yet they 
had worse performance than unadjusted SEs in the case of only a single treated state.  

Furthermore, researchers and policymakers must recognize the inherent implications of a 
fundamentally limited sample size of 50 states (of which perhaps only a few, or even a single 
state implemented the policy of interest) regarding continued reliance on p-values to determine 
statistical significance. Under traditional NHST, correct rejection rates for the majority of 
scenarios was extremely low, lower than 25% across all scenarios considered and only above 
50% for the best performing models and when there was a large effect size (25%) and the most 
balanced allocation to treatment versus control. Additionally, Type I error rates for the majority 
of models relying on NHST when fewer than 15 states are implementing a new policy were 
unreasonably high, meaning these models could yield a significant effect estimate when in fact 

arXix.com Version 
posted June 8, 2021 

14 

 
 
 
such an effect does not exist. It is critical that researchers use models that minimize Type I error 
rates whenever possible; use of standard error corrections to ensure a Type I error rate of 0.05 are 
needed in this context when performing NHST. However, we highly recommend the field overall 
move beyond traditional NHST, given concerns across a range of scientific areas regarding the 
use of often arbitrary p-value thresholds within that framework (41). Over-reliance on such tests 
can lead researchers to miss detecting an effective policy by making a meaningful policy effect 
not â€œstatistically significant.â€  

Critically, the applied field of state-policy research is still implementing traditional NHST, in 

spite of the repeated calls from the field of statistics (41) to move beyond reliance on decisions 
based on whether one has p-values less than 0.05. All of the studies in our recent opioid literature 
review (1) relied on traditional NHST to determine if their findings on the primary policy were 
â€œstatistically significant.â€ One alternative approach that holds promise is the use of Bayesian 
approaches to estimate state-level policy effects. Bayesian methods can be used to estimate 
effects that directly correspond to the likely effects of the yes/no decisions facing policymakers 
considering such legislation (namely, the probability that a given law is associated with an 
increase or a decrease in firearms death), and can also more accurately reflect the large amount 
of uncertainty in these analyses. For an illustration of an Bayesian approach in context of gun 
policy (17). 

We note that our data generating process only generated synthetic observations for the 
treated states in the post-period (in order to induce a policy effect of a known magnitude), rather 
than generating complete trajectories for both treated and untreated states. As such, we (like 
applied researchers) were not privy to the â€œtruthâ€ about whether the parallel counterfactual trend 
assumption, the core identifying DID assumption, was upheld; however, since our treated and 
control states were selected randomly, we do not expect these groups to exhibit systematically 
differential trajectories. We highlight that the parallel counterfactual trends assumption is 
untestable, given that this assumption pertains to unobservable counterfactual outcomes. Yet in 
practice, researchers often conduct a so-called â€œpartial test of parallel trendsâ€ by statistically 
testing whether the pre-intervention trends differ across groups (6, 7). We discourage this 
practice, as it is not informative regarding the actual underlying counterfactuals and indeed may 
induce a false sense of confidence in the validity of the common trends assumption. 
Additionally, a detrended model may be used as a robustness check; if the classic two-way fixed 
effect model and a detrended model that allows for differential state trajectories over time yield 
similar policy effects, this provides some evidence in favor of the common trends assumption. 
See Bilinski and Hatfield (23) and Rambachan and Roth (42) for further discussion of these 
issues and alternative strategies for assessing plausibility of the parallel counterfactual trends 
assumption. We also note that if the parallel counterfactual trends assumption holds on one 
model scale (e.g. linear) it may not automatically hold on other scales (e.g., count). Finally, we 
highlight that an understanding of state policy environments is also key to assessing whether 
common trends is a reasonable assumption. In particular, applied researchers should have 
familiarity with the substantive area, including other policies that states may have enacted during 
the study period that would be expected to additionally impact the outcomes (see Schuler, Griffin 
(18) for further discussion).  

Fundamentally, longitudinal and panel data do not conform to the traditional regression 
assumption of independent and identically-distributed (iid) residuals. When considering various 
modeling approaches, it may be helpful to distinguish between three distinct phenomena that 
contribute to departures from iid residuals and to have diagnostic checks for which deviation 

arXix.com Version 
posted June 8, 2021 

15 

might be occurring in a given data set: outcome autocorrelation, clustering at the state-level, and 
departures from model distributional assumptions. First, some degree of autocorrelation in the 
outcome timeseries is likely. Our results from both the current simulation, as well as the prior 
gun policy simulation, highlight that cause-specific mortality outcomes are likely to highly 
autocorrelated. Similarly, autocorrelation is expected for other key health policy outcomes, such 
as disease-specific incidence rates and healthcare spending measures. The presence of 
autocorrelation following an AR1 structure can be assessed using the Durbin-Watson test; more 
generally, an autocorrelation function (ACF) plot, also called a correlogram, can be used to 
assess the degree of autocorrelation across lagged time periods (Friendly 2002, Durbin and 
Watson 1971). Autocorrelation is effectively addressed through the use of an AR model or GEE 
with an AR correlation structure. See Beard, Marsden (43) for a pragmatic discussion of 
timeseries data analysis in the context of addition research. With regard to state-level clustering, 
one can compare cluster adjusted versus unadjusted standard errors or compute intracluster 
correlation coefficients (ICC) to understand how strong the impact of clustering will have on the 
study design. Though, sample size is a key consideration and such diagnostics like ICCs are not 
reliable when sample sizes are less than 30 (44). Our results indicate that when in the context of 
only a single treated state, cluster and Huber SE adjustments yield worse performance than no 
adjustment. While this has been previously demonstrated in the literature Bertrand, Duflo (14), 
these insights are often not reflected in the applied literature.  

The simulation design has several limitations and future research is needed to build upon this 

work. First, by randomly selecting states to enact a given policy, this simulation represents the 
simplified scenario in which there is no confounding by observed or unobserved covariates 
(including lagged values of the outcome). Future simulation work will consider more complex 
scenarios, including where such confounding exists given the likelihood that states implementing 
certain policies differ from states that do not. A growing set of methods aim to deal with potential 
confounding and need to be considered, including: incorporation of propensity score weighting 
into the DID framework (45), synthetic control methods (46-48) and augmented synthetic control 
methods (49), and doubly-robust DID estimators (50), as well as DID extensions that are robust to 
violations of the parallel trends assumption (51). More broadly, our simulation study did not 
exhaustively compare models used in practice: for example, we did not consider random effect 
models in this study, as prior work indicated that they are not commonly used in practice in 
opioid policy evaluations (1). Second, while the timing of policy enactment varied across treated 
states, our simulated data had a constant policy effect across states and across time, which may 
be an unlikely assumption in some contexts. Recent work has showed that in the presence of 
heterogeneity in policy timing and treatment effects, the classic linear two-way fixed effect DID 
model yields biased treatment effect estimates (11, 52, 53). Future work is needed to investigate 
relative model performance in the context of treatment heterogeneity. Finally, while there are 
numerous outcomes of interest when evaluating the impact of an opioid policy, we focused on 
fatal overdoses given that approximately 1/3 of published opioid policy evaluation studies 
examined this outcome. It is unclear how well the results generalize to other opioid or non-opioid 
outcomes. Future work should entail careful consideration of additional outcomes and extend 
this line of simulation research to identify optimal model specifications in other policy contexts.  
  More broadly, as noted by Schell, Griffin (19): â€œA scientific field built on studies with such 
low power (e.g., less than 0.20) will have a large fraction of significant results that are spurious, a 
substantial proportion of significant effects that are in the wrong direction, and significant effects 
that substantially overestimate the true effect size (54).â€ There is an urgent need for the field to 

arXix.com Version 
posted June 8, 2021 

16 

develop more robust and powerful methods that can be used to help guide state policy. This call is 
needed to address current public health crises in the U.S. (e.g., opioid epidemic, gun violence, 
COVID-19) but also extends beyond to future crises that will develop (e.g., climate change). We 
have to do a better job advancing new approaches that improve accuracy while acknowledge 
uncertainty in state-level policy effects. Research in these areas is needed to help us ensure we 
are meeting the needs of applied policy researchers and key decision makers. 

CONCLUSIONS 
The findings highlight notable limitations of commonly used statistical models for DID designs, 
designs widely used in opioid policy studies and in state policy evaluations more broadly. In 
contrast, the optimal model identified (the AR model) is rarely utilized in state-policy evaluation. 
We urge applied researchers to move beyond the classic DID paradigm and adopt the use of AR 
models.  

arXix.com Version 
posted June 8, 2021 

17 

 
 
 
 
LIST OF ABBREVIATIONS 
AR 

autoregressive 

AR(1) 

autocorrelation structure of order 1 

DID 

GEE 

GLM 

NHST 

NVSS 

difference-in differences 

generalized estimating equations 

generalized linear model 

null hypothesis significance testing 

National Vital Statistics System 

RMSE 

root mean squared error 

SE 

standard error 

DECLARATIONS 
Ethics approval and consent to participate 
The RAND Corporation Institutional Review Board deemed this study exempt (Human Subjects 
Assurance Number 00003425 (6/22/2023)).  
Consent for publication 
Not applicable. 
Availability of data and materials 
The data that support the findings of this study are available from National Vital Statistics 
System (NVSS) Multiple Cause of Death mortality files (1989 through 2018) but restrictions 
apply to the availability of these data, which were used under license for the current study, and 
so are not publicly available. The data can be request under a similar license (data use 
agreement) from the NVSS. 
Competing interests 
The authors declare that they have no competing interests. 
Funding 
This research was financially supported through a National Institutes of Health (NIH) grant 
(P50DA046351) to RAND (PI: Stein). NIH had no role in the design of the study, analysis, and 
interpretation of data nor in writing the manuscript. 
Authors' contributions 
The authors jointly conceived the idea for the study. BG and TS designed, developed and 
implemented the original simulation code; BG lead all adaptions and runs under consultation 
with all authors. EM developed needed graphics and the associated Shiny app for this work. BG, 
MS, and ES drafted the manuscript with input from all authors. All authors extensively edited 
and provided input on all phases of the study and all authors read and approved the final 
manuscript. 
Acknowledgements: The authors would like to thank Kosali Simon and the participants of the 
2019 ASHEcon session that provided helpful comments on an earlier draft. Finally, the authors 
want to thank Hilary Peterson for her assistance with manuscript preparation and submission. 

arXix.com Version 
posted June 8, 2021 

18 

 
 
 
 
REFERENCES 
1. 

Schuler MS, Heins SE, Smart R, Griffin BA, Powell D, Stuart EA, et al. The state of the 
science in opioid policy research. Drug Alcohol Depend. 2020;214:108137. 

2.  Abadie A, Cattaneo M. Econometric methods for program evaluation. Annu Rev Econom. 

2018;10:465-503. 

3.  Basu S, Meghani A, Siddiqi A. Evaluating the health impact of large-scale public policy 
changes: Classical and novel approaches. Annu Rev Public Health. 2017;38:351-70. 

4.  Blundell R, Costa Dias M. Alternative approaches to evaluation in empirical 
microeconomics. Journal of Human Resources. 2009;44(3):565-640. 

5.  O'Neill S, Kreif N, Grieve R, Sutton M, Sekhon JS. Estimating causal effects: Considering 
three alternatives to difference-in-differences estimation. Health Serv Outcomes Res 
Methodol. 2016;16:1-21. 

6.  Wing C, Simon K, Bello-Gomez RA. Designing difference in difference studies: Best 
practices for public health policy research. Annu Rev Public Health. 2018;39:453-69. 
7.  Ryan AM, Burgess JF, Jr., Dimick JB. Why we should not be indifferent to specification 

choices for difference-in-differences. Health Serv Res. 2015;50(4):1211-35. 

8.  Chaisemartin Cd, Dâ€™Haultfoeuille X. Two-way fixed effects estimators with heterogeneous 

treatment effects. 2019. NBER Working Paper 25904 

9.  Daw JR, Hatfield LA. Matching and regression to the mean in difference-in-differences 

analysis. Health Serv Res. 2018;53(6):4138-56. 

10.  Daw JR, Hatfield LA. Matching in difference-in-differences: Between a rock and a hard 

place. Health Serv Res. 2018;53(6):4111-7. 

11.  Goodman-Bacon A. Difference-in-differences with variation in treatment timing. 2018. 

NBER Working Paper 25018 

12.  Brewer M, Crossley T, Joyce R. Inference with difference-in-differences revisited. Journal 

of Econmic Methods. 2017;7(1):2156-6674. 

13.  Abhay A, Donohue III J, Zhang A. The impact of right to carry laws and the NRC Report: 
The latest lessons for the empirical evaluation of law and policy. NBER Working Paper No 
18294. 2014. 

14.  Bertrand M, Duflo E, Mullainathan S. How much should we trust differences-in-

differences estimates? Q J Econ. 2004;119(1):249-75. 

15.  Donald SG, Lang K. Inference with difference-in-differences and other panel data. Rev 

Econ Stat. 2007;89(2):221-33. 

16.  Helland E, Tabarrok A. The fugitive: Evidence on public versus private law enforcement 

from bail jumping. J Law Econ. 2004;47(1):93-122. 

17.  Schell T, Griffin B, Morral A. Evaluating methods to estimate the effect of state laws on 

firearm deaths: A simulation study. RR-2685-RC. Santa Monica, CA: RAND Corporation; 
2019. 

18.  Schuler MS, Griffin BA, CerdÃ¡ M, McGinty EE, Stuart EA. Methodological challenges and 

proposed solutions for evaluating opioid policy effectiveness. Health Serv Outcomes Res 
Method. 2021 Mar;21(1):21-41. 

19.  Schell T, Griffin B, Morral A. Evaluating methods to estimate the effect of state laws on 
firearm deaths: A simulation study. Santa Monica, CA: RAND Corporation; 2018. 
Ioannidis JPA, Stanley TD, Doucouliagos H. The power of bias in economics research. 
Econ J. 2017;127(605):F236-F65. 

20. 

arXix.com Version 
posted June 8, 2021 

19 

21.  Haber N, Clarke-Deelder E, Salomon J, Feller A, Stuart EA. Policy evaluation in COVID-

19: A guide to common design issues. arXiv:2009.01940v5. arXiv. 2020. 

22.  Centers for Disease Control and Prevention. Vital statistics rapid release: Provisional drug 
overdose death counts. 2020. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. 
Accessed 30 April 2021. 

23.  Bilinski A, Hatfield LA. Nothing to see here? Non-inferiority approaches to parallel trends 
and other model assumptions. 2020. Available from: https://arxiv.org/abs/1805.03273 
24.  Wolfers J. Did unilateral divorce laws raise divorce rates? A reconciliation and new results. 

Am Econ Rev. 2006;96(5):1802-20. 

25.  Cochrane D, Orcutt GH. Application of least squares regression to relationships containing 

auto-correlated error terms. J Am Stat Assoc. 1949;44(245):32-61. 

26.  Wooldridge J, Jeffrey M. Econometric analysis of cross section and panel data. 2nd ed. 

Cambridge, MA: MIT Press; 2010. 

27.  Liang K-Y, Zeger S. Longitudinal data analysis using generalized linear models. 

Biometrika. 1986;73(1):13-22. 

28.  White H. A heteroskedasticity-consistent covariance matrix and a direct test for 

heteroskedasticity. Econometrica. 1980;48:817. 

29.  Zeileis A. Econometric computing with HC and HAC covariance matrix estimators. 

Journal of Statistical Software. 2004;11(10):1-17. 

30.  Zeileis A. Object-oriented computation of sandwich estimators. Journal of Statistical 

Software. 2006;16(9):1-16. 

31.  Arellano M. Computing robust standard errors for within-groups estimators. Oxford B 

Econ Stat. 1987;49(4):431-4. 

32.  Ali MM, Dowd WN, Classen T, Mutter R, Novak SP. Prescription drug monitoring 
programs, nonmedical use of prescription drugs, and heroin use: Evidence from the 
National Survey of Drug Use and Health. Addict Behav. 2017;69:65-77. 

33.  Buchmueller TC, Carey C. The effect of prescription drug monitoring programs on opioid 

utilization in Medicare. Am Econ J-Econ Polic. 2018;10(1):77-112. 

34.  McInerney M. The Affordable Care Act, public insurance expansion and opioid overdose 
mortality. 2017. Working Paper 2017-23, University of Connecticut, Department of 
Economics. 

35.  Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death 

rates from drug overdose. Pain Med. 2011;12(5):747-54. 

36.  Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy 

distribution of naloxone and risk of fatal overdose. JAMA Intern Med. 2019;179(6):805-
11. 

37.  Chan NW, Burkhardt J, Flyr M. The Effects of recreational marijuana legalization and 

dispensing on opioid mortality. Economic Inquiry. 2020;58(2):589-606. 

38.  Kilby A. Opioids for the masses: Welfare tradeoffs in the regulation of narcotic pain 

medications. Cambridge: Massachusetts Institute of Technology; 2015. 

39.  Frost J. Regression Analysis: An Intuitive Guide for Using and Interpreting Linear Models. 
2020. https://statisticsbyjim.com/regression/regression-analysis-intuitive-guide/. Accessed 
30 April 2021. 

40.  U.S. Department of Labor. Bureau of Labor Statistics. 2019. https://www.bls.gov/. 

Accessed 30 April 2021. 

arXix.com Version 
posted June 8, 2021 

20 

41.  Wasserstein RL, Lazar NA. The ASA's statement on p-values: Context, process, and 

purpose. Am Stat. 2016;70(2):129-31. 

42.  Rambachan A, Roth J. An Honest Approach to Parallel Trends. 2019. 

https://scholar.harvard.edu/files/jroth/files/roth_jmp_honestparalleltrends_main.pdf. 
Accessed 30 April 2021. 

43.  Beard E, Marsden J, Brown J, Tombor I, Stapleton J, Michie S, et al. Understanding and 
using time series analyses in addiction research. Addiction. 2019;114(10):1866-84. 
44.  Bonett DG. Sample size requirements for estimating intraclass correlations with desired 

precision. Stat Med. 2002;21(9):1331-5. 

45.  Stuart EA, Huskamp HA, Duckworth K, Simmons J, Song Z, Chernew M, et al. Using 
propensity scores in difference-in-differences models to estimate the effects of a policy 
change. Health Serv Outcomes Res Methodol. 2014;14(4):166-82. 

46.  Xu YQ. Generalized synthetic control method: Causal inference with interactive fixed 

effects models. Polit Anal. 2017;25(1):57-76. 

47.  Arkhangelsky D, Athey S, Hirshberg DA, Imbens GW, Wager S. Synthetic difference in 

differences. 2019. https://arxiv.org/abs/1812.09970. Accessed 30 April 2021. 

48.  Abadie A, Diamond A, Hainmueller J. Synthetic control methods for comparative case 
studies: Estimating the effect of California's tobacco control program. J Am Stat Assoc. 
2010;105(490):493-505. 

49.  Ben-Michael E, Feller A, Rothstein J. The augmented synthetic control method. 2020. 

https://arxiv.org/abs/1811.04170. Accessed 30 April 2021. 

50.  Santâ€™Anna PHC, Zhao J. Doubly robust difference-in-differences estimators. J Econom. 

2020;219(1):101-122. 

51.  Ye T, Keele L, Hasegawa R, Small DS. A negative correlation strategy for bracketing in 

difference-in-differences with application to the effect of voter identification laws on voter 
turnout. 2020. arXiv:2006.02423. 

52.  Callaway B, Sant'Anna PHC. Difference-in-differences with multiple time periods and an 

application on the minimum wage and employment. 2018. 
https://arxiv.org/abs/1803.09015v1. Accessed 30 April 2021. 

53.  Sun L, Abraham S. Estimating dynamic treatment effects in event studies with 

heterogeneous treatment effects. 2020. http://economics.mit.edu/files/14964. Accessed 30 
April 2021. 

54.  Gelman A, Carlin J. Beyond power calculations: Assessing Type S (Sign) and Type M 

(Magnitude) errors. Perspect Psychol Sci. 2014;9(6):641-51. 

arXix.com Version 
posted June 8, 2021 

21 

 
 
 
FIGURE LEGEND 
Figure 1. Percent directional bias for the four different linear models considered, all with 
population weights: (1a) the two-way fixed effects model, (1b), the detrended model, (1c) the AR 
model, and (1d) the GEE model. 
Figure 2. Percent directional bias for all models considered in settings with small effect sizes. 
Note: AR = autoregressive, FE = fixed effects, GEE = generalized estimating equation 
Figure 3. Percent magnitude bias for all models considered in settings with small effect sizes. 
Note: Results showing very small grey line at 0 are equal to 0. The statistics shown will slightly 
favor linear over non-linear models since we have to convert magnitude bias into a total count of 
deaths. When magnitude bias measures are converted into the native units of the negative 
binomial models (log risk ratios), the negative binomial models tended to show slightly better 
performance relative to the linear models (as seen here). 
Figure 4. Root mean squared error for (4a) the linear and (4b) nonlinear models under the null 
effect simulation condition. We present this graph stratified by linear and non-linear models, as 
there is no method to compare RMSE across linear and nonlinear models that yields a fair 
comparison. 
Figure 5. Type I error rates for linear model specifications: (5a) the two-way fixed effects 
model, (5b), the detrended model, (5c) the AR model, and (5d) the GEE model. Horizontal line 
denotes the target Type I error rate value of 0.05. 
Figure 6. Type I error rates for the AR models for four different GLMs: (6a) linear 
(unweighted), (6b) log linear (unweighted), (6c) Poisson, and (6d) negative binomial. Horizontal 
line denotes the target Type I error rate value of 0.05. 
Figure 7. Correct NHST rejection rates as a function effect size and number of policy states for 
linear models: (7a) two-way fixed effects DID model, (7b), detrended DID model, (7c) AR model, 
and (7d) GEE model.  Note: All models were fit with population weights 
Figure 8. Average power across all simulation conditions for all models considered in this 
simulation. 

arXix.com Version 
posted June 8, 2021 

22 

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Appendix: Additional technical details and code 

Standard error (SE) estimation: As noted, we estimated the SE in the three ways for each model 

(except GEE): (1) no adjustment; (2) Huber adjustment (robust estimators that attempt to adjust 

the SE for violations of distributional assumptions (White 1980; Zeileis 2004)); and (3) cluster 

adjustment ( adjustments to account for possible violations of the assumed independence of 

observations within states (White 1980; Zeileis 2004, 2006)). To illustrate the differences, we 

can write each adjustment in the following way (STATA Undated): 

(1) No adjustment: This is just the normal ordinary least squares (OLS) estimator. The generic 

formula for a regression model with covariate matrix 

 capturing all the needed data information 

from the sample of observations can be written: 

ð‘¿ð‘¿

where 

â€²
âˆ— (ð‘¿ð‘¿
, k denotes the number of parameters in a model and 

ð‘‰ð‘‰ð‘‚ð‘‚ð‘‚ð‘‚ð‘‚ð‘‚ =   ð‘ ð‘ 

ð‘¿ð‘¿)

âˆ’1

2

2

ð‘ð‘
ð‘–ð‘–=1
estimated residual for the i-th observation.  

1
2
ð‘ð‘âˆ’ð‘˜ð‘˜) âˆ‘ ð‘’ð‘’ð‘–ð‘–

= (

ð‘ ð‘ 

 denotes the 

ð‘’ð‘’ð‘–ð‘–

(2) Huber adjustment: This is the typical robust (unclustered) variance estimator and can be 

written as: 

denotes the i-th observationâ€™s vector of covariate values going into the covariate matrix 

âˆ— [âˆ‘ (ð‘’ð‘’ð‘–ð‘– âˆ— ð‘¥ð‘¥ð‘–ð‘–)

âˆ— (ð‘’ð‘’ð‘–ð‘– âˆ— ð‘¥ð‘¥ð‘–ð‘–)

ð‘‰ð‘‰â„Žð‘¢ð‘¢ð‘¢ð‘¢ð‘¢ð‘¢ð‘¢ð‘¢ =   ð‘ ð‘ 

2

â€²
âˆ— (ð‘¿ð‘¿

ð‘¿ð‘¿)

âˆ’1

ð‘ð‘
ð‘–ð‘–=1

â€²
] âˆ— (ð‘¿ð‘¿

ð‘¿ð‘¿)

âˆ’1

â€²

where 

 .  

ð‘¥ð‘¥ð‘–ð‘– 

ð‘¿ð‘¿
(3) Cluster adjustment: This can be written as: 

where 

â€²
âˆ— ï¿½âˆ‘ ï¿½ð‘¢ð‘¢ð‘—ð‘—â€² âˆ— ð‘¢ð‘¢ð‘—ð‘—ï¿½
ð‘‰ð‘‰ð‘ð‘ð‘ð‘ð‘¢ð‘¢ð‘ð‘ð‘ð‘ð‘¢ð‘¢ð‘¢ð‘¢ =   (ð‘¿ð‘¿
 denotes the number of clusters. 
 and 

â€²
ï¿½ âˆ— (ð‘¿ð‘¿

ð‘¿ð‘¿)

âˆ’1

ð‘¿ð‘¿)

ð‘›ð‘›ð‘ð‘
ð‘—ð‘—=1

âˆ’1

Our simulations were run in R so we used the vcovHC package (RDocumentation Undated) to 

ð‘¢ð‘¢ð‘—ð‘— = âˆ‘

ð‘—ð‘— ð‘ð‘ð‘ð‘ð‘¢ð‘¢ð‘ð‘ð‘ð‘ð‘¢ð‘¢ð‘¢ð‘¢

(ð‘’ð‘’ð‘–ð‘– âˆ— ð‘¥ð‘¥ð‘–ð‘–)

ð‘›ð‘›ð‘ð‘

estimate Huber adjusted SEs by running the following command on the model output (here 

  
  
  
denoted by m1): vcovHC(m1, type="HC0"). As noted in R, type = â€œHC0â€ corresponds to the 

traditional Huber-White robust SE estimator. We confirmed that this Huber SE adjustment is the 

same as the â€œrobustâ€ SE option used by Stata (vce (robust)). To estimate the cluster adjusted SE, 

we utilized the following code to obtain the needed sandwich adjusted SE: 

robust.se <- function(model, cluster){ 
 require(sandwich) 
 require(lmtest) 
 M <- length(unique(cluster)) 
 N <- length(cluster) 
 K <- bigel$rank 
 dfc <- (M/(M - 1)) * ((N - 1)/(N - K)) 
 uj <- apply(estfun(bigel), 2, function(x) tapply(x, cluster, sum)); 
 rcse.cov <- dfc * sandwich(bigel, meat = crossprod(uj)/N) 
 rcse.se <- coeftest(bigel, rcse.cov) 
 return(list(rcse.cov, rcse.se))} 

clustervar<-mapply(paste,"State.",x$STATE,sep="") 
m1$coefficients<-robust.se(m1,clustervar)[[2]] 

We confirmed that the results from this function produces identical SE estimates as the cluster 

adjustment command used in Stata (vce (cluster state)).  

Weighting: State-population weights were treated as analytic weights, not survey weights, within 

the analyses. 

Model differences: Note that since the AR models use lagged outcomes in the regression model, 

they utilized one less year of data from the time series than the other models considered. 

 
 
 
Code. We are currently finishing a codebase that will be placed on GitHub allowing for easy 

replication and extension of our code for running the simulations in this study. Here, we copy a 

sample run for one model (the unweighted linear two-way fixed effects model) over the null 

and assuming a 5% effect of the simulated law. 

rm() 

library(DataCombine) 

library(MASS) 

library(sandwich) 

library(lmtest) 

############################################# 

##Functions 

############################################# 

#function needed for slow coding 

const<-function(m) 

{ 

  v=0 

  if(m!=0) 

  { 

    for(i in 1:m) 

    { 

      v=v+i 

    } 

  } 

  return(v) 

} 

#function needed for slow coding 

slow.acting<-function(month,length,monthly.effect) 

{ 

  top=length-1 

  total.times<-c(1:top) #creating length+1 spline values for the slow acting time span 

 
  #compute year 1 average effect 

  Fraction.year.enacted<-(13-month)/12 

  Average.effect.while.enacted =0.5*Fraction.year.enacted*(1/length)  

  Average.effect.over.year1 = Fraction.year.enacted*Average.effect.while.enacted            

  values.midyrs<-Average.effect.over.year1 + total.times*(1/length) 

  value.last.yr<-((13-month)*1+(month-1)-const(month-1)*monthly.effect)/12  

  values=c(Average.effect.over.year1,values.midyrs,value.last.yr) 

  return(values) 

} 

# calculate mean squared error 

mse<-function(x) 

{ 

  return(mean(x^2,na.rm=T)) 

} 

#Set p-values so denote if result statistically signifcant at alpha = 0.05 level 

#0 for p>=0.05 and 1 for p<0.05 

pval.bin<-function(p) 

{ 

  p[p<0.05]=1 

  p[p!=1]=0 

  return(p) 

} 

# Calculate correction factor for standard error  

corr.factor<-function(t.stats) 

{ 

  f.stats=(t.stats)^2 

  f.stats=sort(f.stats) 

  high.cut=0.95*iters 

  femp95=f.stats[high.cut] 

  freal=qf(.95,1,Inf) 

  corr.factor=sqrt(femp95/freal) 

  return(corr.factor) 

} 

#formula for correcting p-values using correction factor 

adj.ps<-function(regn.coeffs,ses,cf) 

{ 

  adj.ses=sqrt(ses)*cf 

  low95=regn.coeffs-1.96*adj.ses 

  high95=regn.coeffs+1.96*adj.ses  

  new.p=rep(0,iters) 

  for(i in 1:iters) 

  { 

    if(low95[i]<0&high95[i]>0) 

    { 

      new.p[i]=1 

    }else{ 

      new.p[i]=0 

    } 

  } 

  return(new.p)  

} 

#type S   

type.s<-function(betas,pvals,effect.direction) 

{ 

  if(length(betas[pvals<0.05])!=0) 

  { 

    if(effect.direction=="neg"){ 

      a=length(betas[betas>0&pvals<0.05])/length(betas[pvals<0.05]) 

    }else{ 

      a=length(betas[betas<0&pvals<0.05])/length(betas[pvals<0.05]) 

    } 

  }else{ 

    a=0 

  } 

  return(a) 

} 

#correct rejection rate 

test.cf<-function(regn.coeffs,ses,cf,effect.direction) 

{ 

  adj.ses=sqrt(ses)*cf 

  low95=regn.coeffs-1.96*adj.ses 

  high95=regn.coeffs+1.96*adj.ses 

  new.p=rep(0,iters) 

  for(i in 1:iters) 

  { 

    if(low95[i]<0&high95[i]>0) 

    { 

      new.p[i]=0 

    }else{ 

      new.p[i]=1 

    } 

  } 

  #switch findings in the incorrect direction to 0's 

  if (effect.direction == "pos"){ 

    new.p[new.p==1&regn.coeffs<0]=0 

  }else{ 

    new.p[new.p==1&regn.coeffs>0]=0 

  } 

  return(sum(new.p)/iters) #should be ~0.05 

} 

#needed for performing cluster adjustment to standard errors 

robust.se <- function(model, cluster){ 

 require(sandwich) 

 require(lmtest) 

 M <- length(unique(cluster)) 

 N <- length(cluster) 

 K <- model$rank 

 dfc <- (M/(M - 1)) * ((N - 1)/(N - K)) 

 uj <- apply(estfun(model), 2, function(x) tapply(x, cluster, sum)); 

 rcse.cov <- dfc * sandwich(model, meat = crossprod(uj)/N) 

 rcse.se <- coeftest(model, rcse.cov) 

 return(list(rcse.cov, rcse.se)) 

} 

################################# 

#Simulation function 

################################# 

# The main simulation generator and output function 

run.sim = function(code.speed, effect.direction){ 

  #creating matrix to hold 4 key regression results a 

  #Column 1 = estimated effect (regression coefficient) 

  #Column 2 = estimated variance 

  #Column 3 = t-statistic 

  #Column 4 = p-value 

  stats.matrix1=list(matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4))  

  stats.matrix1h=list(matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4))  

  stats.matrix1cl=list(matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4))  

  stats.matrix1hcl=list(matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4),matrix(0,iters,4))  

  #use same seed for all runs so run on same simulated dataset for each model 

  set.seed(1234567)   

  #outer loop covers 4 different treated states sample sizes 

  for(j in 1:4) 

  { 

    n.trt=n.states[j] 

    #inner loop created the needed iters of simulated datasets  

    for(k in 1:iters) 

    { 

      #Create vector of state names to sample from 

      state.names=as.character(unique(x$STATE))  

      #randomly sample the exposed/treated states 

      z=sample(state.names,n.trt,replace=FALSE)  

      #randomly sample the year the law was enacted for each treated states 

   
      years.enacted=sample(c(2002:2013),n.trt,replace=TRUE)  

      #randomly sample the month the law was enacted for each treated state 

      month.enacted=sample(c(1:12),n.trt,replace=TRUE)   

      #create levels coding  

      x$levels.coding=rep(0,nrow(x)) 

      if (code.speed == "slow") { 

        #Slow coding - assumes it takes 3 years for a law to become fully effective 

        length=3          

        #loops through for each treated/exposed state to create the needed slow coding levels coding 

        for(s in 1:n.trt) 

        { 

          month=month.enacted[s] 

          values=slow.acting(month,length,monthly.effect = (1/length)/12) 

          mark=length+1 

          mark2=years.enacted[s]+length 

          check=2016-years.enacted[s] 

          if(check>=length(values)) 

          { 

            x$levels.coding[x$STATE==z[s]&x$YEAR>=years.enacted[s]][1:mark]=values 

            x$levels.coding[x$STATE==z[s]&x$YEAR>mark2]=1 

          }else{ 

            hold=check+1 

            x$levels.coding[x$STATE==z[s]&x$YEAR>=years.enacted[s]][1:hold]=values[1:hold] 

          } 

        } 

        #Creating change levels coding for models for treated/exposed states 

        x$ch.levels.coding=rep(0,nrow(x)) 

        for(s in 1:n.trt) 

        { 

          levels=x$levels.coding[x$STATE==z[s]] 

          levels.shifted=c(0,levels[-length(levels)])  

          x$ch.levels.coding[x$STATE==z[s]]=levels-levels.shifted 

        ] 

      }else{ 

        if (code.speed == "instant"){ 

          #Instantaneous coding version 

          for(s in 1:n.trt) 

          { 

            x$levels.coding[x$STATE==z[s]&x$YEAR==years.enacted[s]]=(12-month.enacted[s]+1)/12 

            x$levels.coding[x$STATE==z[s]&x$YEAR>years.enacted[s]]=1 

          } 

          #Creating change levels coding  

          x$ch.levels.coding=rep(0,nrow(x))  

          for(s in 1:n.trt) 

          { 

            levels=x$levels.coding[x$STATE==z[s]] 

            levels.shifted=c(0,levels[-length(levels)])  

            x$ch.levels.coding[x$STATE==z[s]]=levels-levels.shifted 

          } 

        } 

      } 

#GENERATING OUTCOMES 

      if(effect.direction !="null"){ 

        ################## 

        #Introduce treatment effects to state observations 

        ################## 

          if (link == "linear"){ 

          x$cr.adj=x$Crude.Rate+te*x$levels.coding 

        } 

        if (link == "log-lin"){ 

          x$logY.adj=log(x$Crude.Rate+x$Crude.Rate*(te-1)*x$levels.coding) 

          x$cr.adj=exp(x$logY.adj) 

        } 

        if (link == "log"){ 

          x$deaths.adj=x$Deaths+x$Deaths*(te-1)*x$levels.coding 

           
          x$deaths.adj=round(x$deaths.adj) 

          x$cr.adj=(x$deaths.adj*100000)/x$POPULATION 

        } 

        #need lags to be computed on new adjusted crude rates as potential control covariate in models 

        mark1=dim(x)[2]+1 

        x <- slide(x, Var = "cr.adj", GroupVar = "STATE", slideBy = -1) 

        colnames(x)[mark1] <- "lag1" 

        #x$lag1 = x$cr.adj.lag1       

        }else{ 

x$cr.adj=x$Crude.Rate  

x$deaths.adj=x$Deaths  

        x$lag1 = x$crude.rate.lag1 

x$logY.adj=log(x$Crude.Rate)  

x$lag1 = x$cr.adj.lag1       

      }      

      ##################################################### 

      # Insert Regression Model Here - Illustrative Example 

      # the formula line below can be changed to include different effects, 

      # including lags (use variable "lag1"), change-levels coded effects variables. 

      # the model line can substitute other models. 

  #let's test two way fixed effects WITHOUT population weights 

m1=lm(cr.adj~levels.coding+as.factor(YEAR)+as.factor(STATE)+ UNEMPLOYMENTRATE,data=x) 

     ##################################################### 

      #store results 

      stats.matrix1[[j]][k,1]= summary(m1)$coefficients[2,1] #regression coefficient 

      stats.matrix1[[j]][k,2]= summary(m1)$coefficients[2,2]^2 #se^2 

      stats.matrix1[[j]][k,3]= summary(m1)$coefficients[2,3] #t-statistics 

      stats.matrix1[[j]][k,4]= summary(m1)$coefficients[2,4] #p-value 

#Coding for implementing adjustments to standard errors 

      #Huber adjustment requires library("sandwich") 

      cov.m1<- vcovHC(m1, type="HC0") 

      std.err <- sqrt(diag(cov.m1))       

      stats.matrix1h[[j]][k,1]= coef(m1)[2] 

       
       
       
 
      stats.matrix1h[[j]][k,2]= std.err[2]^2 #var 

      stats.matrix1h[[j]][k,3]= coef(m1)[2]/std.err[2] 

      stats.matrix1h[[j]][k,4] =2*pnorm(abs(coef(m1)/std.err), lower.tail=FALSE)[2] 

      # Arellano 

      cov.m1<- vcovHC(m1, type="HC1",cluster="STATE",method="arellano") 

      std.err <- sqrt(diag(cov.m1)) 

      stats.matrix1hcl[[j]][k,1]= coef(m1)[2] 

      stats.matrix1hcl[[j]][k,2]= std.err[2]^2 #var 

      stats.matrix1hcl[[j]][k,3]= coef(m1)[2]/std.err[2] 

      stats.matrix1hcl[[j]][k,4] =2*pnorm(abs(coef(m1)/std.err), lower.tail=FALSE)[2] 

      #Cluster adjustment only 

      #Create the new variable with appropriate level names. 

      clustervar<-mapply(paste,"State.",x$STATE,sep="") 

      #Save the coefficient test output to an element in the model object 

      m1$coefficients<-robust.se(m1,clustervar)[[2]] 

      stats.matrix1cl[[j]][k,1]= m1$coefficients[2,1] #bias 

      stats.matrix1cl[[j]][k,2]= m1$coefficients[2,2]^2 #var 

      stats.matrix1cl[[j]][k,3]= m1$coefficients[2,3] 

      stats.matrix1cl[[j]][k,4]= m1$coefficients[2,4] #p-value 

       ####################################################### 

      # remove generic lag variable 

      x = x[, -which(names(x) == "lag1")] 

      print(k) 

    } #ends k loop 

    print(j) 

  } #ends j loop 

  ######################################################## 

  #Compute Summary Statistics for runs  

  ######################################################## 

  if (effect.direction == "null"){ 

#expanding so this holds 16 rows for 4 n.trt times 4 SE models 

    stats1=matrix(0,16,5)  

    #loop through 4 sample sizes for the number of treated states 

    cols=c(1,2,5) 

    for(j in 1:4) 

    { 

mark1=(j-1)*4+1 

mark2=mark1+1 

mark3=mark2+1 

mark4=mark3+1 

      #Computes Type I Error 

stats1[mark1,4]=mean(pval.bin(stats.matrix1[[j]][,4])) 

stats1[mark2,4]=mean(pval.bin(stats.matrix1h[[j]][,4])) 

stats1[mark3,4]=mean(pval.bin(stats.matrix1cl[[j]][,4])) 

stats1[mark4,4]=mean(pval.bin(stats.matrix1hcl[[j]][,4])) 

      #Computes Simple Mean Summaries for the other columns 

stats1[mark1,cols]=apply(stats.matrix1[[j]][,1:3],2,mean) 

stats1[mark2,cols]=apply(stats.matrix1h[[j]][,1:3],2,mean) 

stats1[mark3,cols]=apply(stats.matrix1cl[[j]][,1:3],2,mean) 

stats1[mark4,cols]=apply(stats.matrix1hcl[[j]][,1:3],2,mean) 

      #Computes MSE under null 

stats1[mark1,3]=mse(stats.matrix1[[j]][,1]) 

stats1[mark2,3]=mse(stats.matrix1h[[j]][,1]) 

stats1[mark3,3]=mse(stats.matrix1cl[[j]][,1]) 

stats1[mark4,3]=mse(stats.matrix1hcl[[j]][,1])       

    } 

    file1=paste("Summaries_Null_",code.speed,"_", model.name,".csv",sep="") 

    file1=paste("Summaries_Null_",code.speed,"_", model.name,".csv",sep="") 

    n.states.exp=c(rep(n.states[1],4),rep(n.states[2],4,),rep(n.states[3],4),rep(n.states[4],4)) 

    se.adj=c(rep(c("none","Huber","Cluster","Huber-Cluster"),4)) 

    stats1=as.data.frame(cbind(n.states.exp,se.adj,stats1)) 

    names(stats1)<-c("n.trt","se.adj","RegnCoeff","AveModelSE","MSE","TypeI","Tstat") 

    write.table(stats1,file=file1,sep=",",row.names=FALSE) 

    #Compute Correction Factors 

    stats1.cf=rep(0,16) 

   #compute for each number of treated/exposed states 

    for(j in 1:4) 

    { 

mark1=(j-1)*4+1 

mark2=mark1+1 

mark3=mark2+1 

mark4=mark3+1 

stats1.cf[mark1]=corr.factor(stats.matrix1[[j]][,3]) 

stats1.cf[mark2]=corr.factor(stats.matrix1h[[j]][,3]) 

stats1.cf[mark3]=corr.factor(stats.matrix1cl[[j]][,3]) 

stats1.cf[mark4]=corr.factor(stats.matrix1hcl[[j]][,3]) 

    } 

    file2=paste("Correction_Factors_",code.speed,"_",model.name,".csv",sep="") 

    write.table(stats1.cf,file2,sep=",",row.names=F) 

 # if instead it is a positive or negative effect run...   

  }else{ 

    stats1=matrix(0,16,3) 

    #Calculate bias  

    if (link=="linear"){ 

      for(j in 1:4) 

      { 

mark1=(j-1)*4+1 

mark2=mark1+1 

mark3=mark2+1 

mark4=mark3+1 

#bias 

tot.pop=sum(as.numeric(x$POPULATION)) 

ave.pop.per.yr=tot.pop/length(unique(x$YEAR)) 

APS = ave.pop.per.yr/100000 

TE = target.d  

stats1[mark1,1]=mean(stats.matrix1[[j]][,1]*APS-TE) 

stats1[mark2,1]=mean(stats.matrix1h[[j]][,1]*APS-TE) 

stats1[mark3,1]=mean(stats.matrix1cl[[j]][,1]*APS-TE) 

     
       
       
       
       
       
stats1[mark4,1]=mean(stats.matrix1hcl[[j]][,1]*APS-TE) 

      } 

    }else{ 

      for(j in 1:4) 

      { 

mark1=(j-1)*4+1 

mark2=mark1+1 

mark3=mark2+1 

mark4=mark3+1 

tot.deaths=sum(x$Deaths) 

ave.per.yr=tot.deaths/length(unique(x$YEAR)) 

        ADPY = ave.per.yr 

TE = target.d  

stats1[mark1,1]=mean((exp(stats.matrix1[[j]][,1])-1)*ADPY-TE) 

stats1[mark2,1]=mean((exp(stats.matrix1h[[j]][,1])-1)*ADPY-TE) 

stats1[mark3,1]=mean((exp(stats.matrix1cl[[j]][,1])-1)*ADPY-TE) 

stats1[mark4,1]=mean((exp(stats.matrix1hcl[[j]][,1])-1)*ADPY-TE) 

      } 

    } 

   ######################### 

    #adjusted power & adjusted type S error - requires correction Factor 

    file2=paste("Correction_Factors_",code.speed,"_",model.name,".csv",sep="") 

    cfs=read.table(file2,sep=",",h=T) 

    for(j in 1:4) 

    { 

mark1=(j-1)*4+1 

mark2=mark1+1 

mark3=mark2+1 

mark4=mark3+1 

     #power 

stats1[mark1,2]=test.cf(stats.matrix1[[j]][,1],stats.matrix1[[j]][,2],cfs$x[mark1],effect.direction) 

stats1[mark2,2]=test.cf(stats.matrix1h[[j]][,1],stats.matrix1h[[j]][,2],cfs$x[mark2],effect.direction) 

stats1[mark3,2]=test.cf(stats.matrix1cl[[j]][,1],stats.matrix1cl[[j]][,2],cfs$x[mark3],effect.direction) 

       
       
       
stats1[mark4,2]=test.cf(stats.matrix1hcl[[j]][,1],stats.matrix1hcl[[j]][,2],cfs$x[mark4],effect.direction) 

     #type S error 

stats1[mark1,3]=type.s(stats.matrix1[[j]][,1],adj.ps(stats.matrix1[[j]][,1],stats.matrix1[[j]][,2],cfs$x[mark1]),effect.direction) 

stats1[mark2,3]=type.s(stats.matrix1h[[j]][,1],adj.ps(stats.matrix1h[[j]][,1],stats.matrix1h[[j]][,2],cfs$x[mark2]),effect.direction) 

stats1[mark3,3]=type.s(stats.matrix1cl[[j]][,1],adj.ps(stats.matrix1cl[[j]][,1],stats.matrix1cl[[j]][,2],cfs$x[mark3]),effect.direction) 

stats1[mark4,3]=type.s(stats.matrix1hcl[[j]][,1],adj.ps(stats.matrix1hcl[[j]][,1],stats.matrix1hcl[[j]][,2],cfs$x[mark4]),effect.direction) 

    } 

    if (link=="linear"){ 

      ave.coefficient=stats1[,1]+TE 

      bt=abs(te) 

    }else{ 

      ave.coefficient=stats1[,1]+TE 

      bt=abs(log.te) 

    } 

    ll = list(stats1,ave.coefficient,bt) 

    file3=paste("Results_",effect.direction,"_",code.speed,"_", model.name,".Rdata",sep="") 

    save(ll,file=file3) 

  } 

} 

############################################# 

#Step 1: Prepare the data for the simulation 

############################################# 

setwd("FILL IN") 

load("optic_sim_data_exp.Rdata") 

#################################################################################################### 

#Step 2. Set general simulation parameters 

#################################################################################################### 

# number of iterations 

iters = 5000 

# effect coding, slow or instant 

code.speed = c("instant","slow")[1]   #select coding scheme 

# link type 

# select what type of effect modeling - linear = 1; log-linear = 2; log/count = 3 

link = c("linear", "log-lin", "log")[1]   

# name for current model 

model.name = "Opioid_Mortality_Runs_linear_2wayfe_unwt_smES"  

#Creating 4 variations in sample size that we study  

#Number of exposed/treated states = 1, 5, 15, and then 30 

n.states=c(1,5,15,30) 

############################################################## 

# Step 3. Run null models (instant and slow), and positive 

# and negative models (instant and slow) 

############################################################# 

# cycle through simulations of the null, and positive and negative effects 

for (i in c("null","pos","neg")){ 

  if (i != "null"){ 

    #Generate effect magnitudes 

    if (link=="linear"){ 

      #SIMULATING NONZERO POSITIVE EFFECTS FOR LINEAR MODELS 

      #first we figured out what % change equals ~700 deaths 

      tot.pop=sum(as.numeric(x$POPULATION)) 

      ave.pop.per.yr=tot.pop/length(unique(x$YEAR)) 

      APS = ave.pop.per.yr/100000 

      target.d=700 

      TE = target.d 

      te=TE/APS 

      if (i=="neg") 

{  

te=-te 

target.d=-target.d 

} 

    }else{ 

      #SIMULATING NONZERO EFFECTS FOR COUNT MODELS AND LOG(Y) MODELS 

      #first we figured out what % change equals ~700 deaths 

      tot.deaths=sum(x$Deaths) 

      ave.per.yr=tot.deaths/length(unique(x$YEAR)) 

 
 
 
 
      target.d=700 

      percent.change=target.d/ave.per.yr 

      if (i=="neg"){ 

        delta=1-percent.change 

target.d=-target.d 

      }else{ 

        delta=1+percent.change 

      } 

      te=delta 

      log.te=log(delta) 

    } 

  } 

  # for each null, positive, or negative effect 

  # cycle through simulations with instant and slow coding 

  for (j in c("instant","slow")){ 

    dummy = run.sim(effect.direction=i, code.speed = j) 

 } 

} 

############################################################## 

# Step 4. Organize resulting data 

############################################################# 

for (i in c("instant","slow")){ 

  file3=paste("Results_","neg","_",i,"_", model.name,".Rdata",sep="") 

  load(paste(file3,sep="")) 

  ave.coefficient.neg = ll[[2]] 

  results.neg.bias  = ll[[1]][,1] 

  results.neg.power = ll[[1]][,2] 

  results.neg.typeS = ll[[1]][,3] 

  file3=paste("Results_","pos","_",i,"_", model.name,".Rdata",sep="") 

  load(paste(file3,sep="")) 

  ave.coefficient.pos = ll[[2]] 

 
 
 
  results.pos.bias  = ll[[1]][,1] 

  results.pos.power = ll[[1]][,2] 

  results.pos.typeS = ll[[1]][,3] 

    if(link=="log"){bt.count=ll[[3]]} else{bt.linear=ll[[3]]} 

  if(link=="log-lin"){bt.count=ll[[3]]} else{bt.linear=ll[[3]]}  

    #power 

  results.power=(results.neg.power+results.pos.power)/2 

  #type S 

  results.typeS=(results.neg.typeS+results.pos.typeS)/2 

  #bias 

  results.bias=(results.neg.bias+results.pos.bias)/2 

  results.magbias=(results.pos.bias-results.neg.bias)/2 

  n.states.exp=c(rep(n.states[1],4),rep(n.states[2],4,),rep(n.states[3],4),rep(n.states[4],4)) 

  se.adj=c(rep(c("none","Huber","Cluster","Huber-Cluster"),4)) 

  all.results=cbind(n.states.exp,se.adj,results.bias,results.magbias,results.typeS,results.power) 

  all.results<-as.data.frame(all.results) 

  names(all.results)<-c("n.states.exp","se.adj","results.bias","results.magbias","results.typeS","results.power") 

  file4 = paste("Results_NonZeroEffect_",i,"_",model.name,".csv",sep="")  

  write.table(all.results,file=file4,sep=",",row.names=FALSE) 

} 

#compile into 2 columns 

file4 = paste("Results_NonZeroEffect_","slow","_",model.name,".csv",sep="") 

slow.results = read.table(file4,sep=",",header=TRUE) 

file4 = paste("Results_NonZeroEffect_","instant","_",model.name,".csv",sep="") 

instant.results =read.table(file4,sep=",",header=TRUE) 

results.power=cbind(instant.results$results.power,slow.results$results.power) 

results.typeS=cbind(instant.results$results.typeS,slow.results$results.typeS) 

results.bias=cbind(instant.results$results.bias,slow.results$results.bias) 

results.magbias=cbind(instant.results$results.magbias,slow.results$results.magbias) 

  n.states.exp=c(rep(n.states[1],4),rep(n.states[2],4,),rep(n.states[3],4),rep(n.states[4],4)) 

  se.adj=c(rep(c("none","Huber","Cluster","Huber-Cluster"),4)) 

all.results=cbind(n.states.exp,se.adj,results.bias,results.magbias,results.typeS,results.power) 

all.results<-as.data.frame(all.results) 

names(all.results) =c("n.states","se.adj","results.bias.instant","results.bias.slow","results.magbias.instant",                             

"results.magbias.slow","results.typeS.instant","results.typeS.slow", 

                               "results.power.instant","results.power.slow") 

file4 = paste("All_Results_NonZeroEffect_",model.name,".csv",sep="") 

write.table(all.results,file4,sep=",",row.names=F) 

 
